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Materials. Yeast extract, tryptone, and isopropyl-β-D-thiogalactopyranoside (IPTG) were 
purchased from DOT Scientific. 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES), glycerol, and imidazole, were purchased from Fisher Scientific. Kanamycin 
was purchased from Teknova. Sodium chloride (NaCl), sodium hydroxide (NaOH), 
ammonium chloride (NH4Cl) and hydrochloric acid (HCl) were purchased from EMD 
Millipore. Dithiothreitol (DTT) and 1,4-dihydroxynapthalene (NQ) were purchased from 
Alfa Aeser. NiII-nitrilotriacetic acid agarose (Ni-NTA) resin and 96-well crystallography 
screens were purchased from Qiagen. All other chemicals used were purchased from 
Sigma Aldrich. Oligonucleotide primers were purchased from Integrated DNA 
Technologies. PCR reagents, restriction enzymes/buffers, and T4 DNA ligase were 
purchased from New England Biolabs. Escherichia coli (Ec) DH5 α, BL21 (DE3), and 
the pET-28a(+) vector were purchased from Novagen. All crystallography supplies were 
purchased from Qiagen and Hampton Research. 
Au a subunit: 
CACTATAGGGCGAATTGAAGGAAGGCCGTCAAGGCCGCATCATATGACCTAT
AGCAATACCCGTCCGGATTTTGAATGGCTGAATGAAGATAGCCGTCTGTTTCT
GCAGCGTGGTTATCTGCTGGAAGGCACCACCGCACTGGAACGTATTCGTTTTA
TTGCAGAACATGCCGAACACAAACTGGGTATTGAAGGTTATGCCGATAAATT
CTACCATTATATGGCACGCGGTTATTTTAGCCTGAGCAGCCCGATTTGGAGCA
ATTTTGGTCTGGATCGTGGTCTGCCGATTAGCTGTTTTGGTAGCTATATTGGT
GATAGCATCCACGAAATTATGGTTACCACAGCCGAAGTTGGCATGATGAGCA
AAATTGGTGGTGGCACCAGCGCATATTTTGGTGATATTCGTCCGCGTGGTAGC
GCCATTAAAAACAATGGTAAAAGTGATGGCAGCTTTAACTTTAGCAAACTGT
TTGATACCGTGATCGATGTTATTAGCCAGGGCACCAGCCGTAAAGGTCAGTTT
GCAGGTTATATTGATATCGAACATGGCGATATTGATGAGTGGCTGGATATTC
ATACCGAAGGTAATCCGATTCAGCTGATGTATTATGGTGTTTGCGTTGGTCAT
GATTGGCTGGAAAGCATGAAAGCCGGTGATCCGTATAAACGTCAGCTGTGGG
CAAAACTGCTGCAGCGTAAAACCGAAACCGGTATTCCGTACCTGTTTTTCAA
AGATAATGCAAATGCAGGTCGTCCGGATGTGTATAAAGATAAAAACATGACC
GTTCATGCCAGCAATCTGTGTACAGAAATTATGCTGCCGAGCAGCAATGATG
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AAAGCTTTGTTTGTTGTCTGAGCAGCATGAACCTGCTGTATTTTGATGAATGG
AAAGATACCGAAGCACCGGAAGTGCTGACCTATTTTCTGGATGTTGTTATGA
GCGAGTTCATCGAGAAAAGCAAAGATATGCCGTTTCTGGATCGCGCACATCG
TTTTGCAACCCGTCATCGTGCACTGGGTCTGGGTGTTCTGGGTTGGCATAGCT
ATCTGCAGGCAAATAACATTGCCTTTGATAGCTTTCAGGCCATGCAGAAAAA
TAACCTGATCTTCAAAACCCTGCAAGAAAAAACCCTGAAAGCAAGCCAAGA
ACTGGCCAAACGTTTTGGTGAACCGGAAATTCTGAAAGGTTATGGTCGTCGT
AATACCACCCTGATGAGCATTGCACCGACCAAAAGCAGCAGCTTTATTCTGG
GTAGCGTTAGCCCGAGCGTTGAACCGTTTAAAAGCAACTATTATGTGAAAGA
TCTGGCGAAAATCAAAACCGTGTATAAAAACCCGTTCCTGGAAAAACTGCTG
CAAGAAAAAGGTCTGGATACCGAAGAAATTTGGGAAAGCATTCTGCATAATG
ATGGTAGCGTTCAGCATCTGGAACAGCTGACCGATGAAGAAAAAGAAGTGTT
TAAAACCTTCAGCGAAATTAGCCAGCTGAGCGTTATTCAGCAGGCAGCACAG
CGTCAGAAATATATCGATCAGGGTCAGAGCATTAACATTATGGTTCATCCGG
CAACACCGGCACGTGATCTGAATCAGCTGTATCTGACCGCAGAAGAACTGGG
CCTGAAAAGTATCTATTATCAGTATAGCATGAGCGCAGCCCAGGTGTTTAATC
GTAATCTGCTGAGCTGTAGCAGCTGTGAAGGTTAACTCGAGCTGGGCCTCAT
GGGCCTTCCTTTCACTGCCCGCTTTCCAG 
Au b  subunit:  
ATGAGCAAACGCAACCTGTTTGAAAAACGCCTGAACATCAAACCGTATGAAT
ATCCGGAACTGCTGGAATTTAAAGATGCAATTCGTCATAGCTATTGGCTGCAC
ACCGAATTTAACTTTACCGGTGATATTCAGAACTACCGCATCGATATTAATGA
TCATGAACGTCATGTTCTGACCCGTGCAATGCTGGCAATTAGCCAGGTTGAA
GTTAATGTGAAACGTTTTTGGGGTGAGCTGTATCGCTATTTTCCGAAACCGGA
AATGGATGATGTTGGTGGCACCTTTGCAGAAAGCGAAGTTCGTCATAAAGAT
GCCTATAGCTTTCTGCTGGAAAAACTGGGTCTGAACGAAATGTTTAGCCAGA
TTCAGGATATTGAACCGCTGATGAATCGTATCCGTTATATGGAAAGCTTTATG
AAAGACAAAGATGCCGGTAAAGGTGAATTTGTTCTGAGCCTGGTTCTGTTTA
GCCTGTTTGTTGAACATATTAGTCTGTTTGGCCAGTTTCTGATCATGATGAGC
TTTAACAAACACAAAAACCTGTTTAAAGGCATCAGCAATGCAGTTGAAGCAA
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CCAGCAAAGAAGAAGAAATTCACGGCAAATTTGGCATTGCCCTGTATGAAAT
TCTGCGTGATGAACATAGCGAACTGTTTACACCGGAATTTTTCGAAGAACTG
AAAACCCTGAGCACCCAGGCATTTGAAGCAGAATGTGGTATTCTGGATTGGA
TCTTTGAAGAAGGTGATCTGAGCTTTATTAGCCGTGAAGCAGTGGAAAACTA
TATTCGTAGCCGCTATAATAACAGCCTGATGACCCTGGGTCTGGAACCGCCTT
ATGACGTTAACCCTGAACTGCTGAAAGAAACCGAATGGTTTGATATTGAAAT
CCTGTCCACCAAAGAAACGGATTTTTTCAATAAACGCAGCACCGATTATAGC
AAAAAAATGAAACAAATCACCGCAGACGACCTGTTCTAA 
Fj Thioredoxin (Trx): 
ATGGCATTAGCAATAACAGATGCTACTTTTGACGAAGTAGTTTTAAAATCAG
ATAAACCAGTAATGGTGGATTTTTGGGCAGCATGGTGCGGTCCTTGTAGAAT
GGTTGGTCCAATCATTGACCAATTAAGCGATGAATATGCAGGAAAAGTTGTG
GTTGGTAAAGTTGATGTAGATGCTAACCAGGAATTTGCTGCTAAATATGGTGT
GCGTAACATACCAACCGTTTTGGTGTTTCATAACGGTGAAGTAGTAGGAAAA
CAAGTTGGAGTTGCTCCAAAACAAACCTACGCTGACAGCTTAGACGCTTTGTT
GTAA 
Fj Thioredoxin Reductase (Trr): 
ATGTCAGATACAATCGAAAAAATTAAATGCCTTATTATAGGTTCTGGCCCTGC
GGGTTATACTGCAGCTATTTATGCTGCCAGAGCAAACATGAATCCGGTTTTAT
ACCAAGGAATGCAGCCTGGAGGTCAGTTAACGACAACTAATGAAGTAGAAA
ATTTTCCTGGTTATGTTGATGGTGTTACAGGACCAGAAATGATGATACAGTTA
CAAGAACAAGCAAAACGCTTTGGTGCTGATATTCGTGACGGCTGGGCTACAA
AAGTTGATTTTTCTGGTGGAATTCATAAAGTTTGGATTAACGATTCAATCGAA
TTGCACTGCGAAACAGTAATTATTTCGACAGGTGCTTCGGCTAAATATTTAGG
ATTACCTTCTGAACAACATTATTTGAATATGGGAGGCGGAGTTTCTGCCTGCG
CTGTCTGTGATGGGTTTTTCTACCGTAATCAGGAAGTAGTAATTGTAGGAGCA
GGAGATTCTGCTTGTGAAGAAGCACATTACTTGTCTAAACTTTGTAAAAAAGT
AACGATGTTAGTAAGAAGCGAAAAATTCAGAGCTTCTAAAATTATGGAAGAA
AGAGTTCGTAAAACTGAAAATATCGAAATCTTAATGAATCATGATACTCTTG
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AAGTTTTAGGAGACAATAATGTGGTTCACGCTATTAAAGCTTTAAACAAAAC
AACTGGCGAAACAATCGAAATTCCTGCAACCGGATTTTTTGTAGCAATTGGG
CACAAACCAAATACAGATATTTTTAAAGATTACATTACTCTTGATGAAACAG
GATATATCATAAATACTCCAGGAACATCTAAAACTAATGTTGAAGGTGTTTTC
GTAGCCGGAGATGCTGCAGACCATGTATACCGTCAGGCAATTACTGCTGCAG
GTACAGGATGTATGGCAGCACTTGATGCTGAAAGATATTTGGCTTCTCAAGA
ATAA 
Construction of Vector for Overexpression C96S variant of Fj a:  The Cys96 to Ser 
substitution was introduced into the Fj RNR a protein by site-directed mutagenesis. The 
pET28a-Fj a wt was used as the template and the following mutagenic primers encoding 
the substitution were used: Forward: 5’- AGTTTTAACGTTCACGTTCCGG - 3’ and 
Reverse: 5’- AGAAATAGGCAGACCTCTTTCGG - 3’.   
Overexpression and purification of Au b: N-terminally His6-tagged Au b was expressed 
from the plasmid pET28a(+) and grown in LB-rich medium at 37 °C with 180 rpm 
shaking. When the cells reached OD600 ~ 0.7-0.8, overexpression was induced by 
addition of IPTG to a final concentration of 0.5 mM. Pelleted cells were resuspended in 
Buffer C with 10 mM imidazole, lysed via sonication, and purified via NiII-NTA 
chromatography using buffer C with 250 mM imidazole to elute the protein. Fractions 
containing Au b were concentrated in a 30 kDa MWCO centrifugal device (Pall 
Corporation) and metals were removed by dialysis in buffer C with 10 mM EDTA, 
followed by dialysis into buffer B for a DEAE anion exchange step. Au b was eluted 
using a 50 mM – 2 M salt gradient applied over 15 column volumes. Protein-containing 
fractions were concentrated in a 30 kDa MWCO filter device (Pall Corporation) and 
injected onto a HiLoad 16/600 Superdex 200 (S200) gel filtration column connected to an 
ÄKTA Pure FPLC system (GE Healthcare) and eluted in an isocratic step into buffer C. 
Protein-containing fractions were concentrated, flash-frozen in liquid N2, and stored at -
80 °C until further use. Protein concentration was determined spectrophotometrically 
using the computationally derived molar absorption coefficients (ε280) of 41,370 for Au b 
monomer (ExPASY).  
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Au b was activated by addition of addition of 1.5 eq. Mn/b and 1 eq. naphthoquinone 
(NQ)/b. 1 
SAXS characterization of Fj b subunit: Even after centrifugation for 10 min at 10,000g, 
samples of activated Fj β displayed a high level of aggregation at all concentrations, 
based on a poor Guinier fit. The aggregated fraction could be removed by two different 
methods: (1) by centrifuging 50 µL aliquots in an air-driven ultracentrifuge (Beckman 
Coulter Airfuge) for 30 min at max speed immediately prior to measurements, from 
which the top 30 µL from each aliquot were carefully removed and used for SAXS 
analysis (~10 mg/ml, 25 µM); or (2) by using the in-line size exclusion column, as 
described for the α subunit. All data for Fj b by itself were collected in buffer A [50 mM 
HEPES, pH 7.6, 150 mM NaCl, 5% glycerol]. 
 
SAXS characterization of the Fj a:b complex: SEC-SAXS was used to obtain information 
about the stoichiometry of the active holoenzyme complex. In an attempt to stabilize the 
complex under turnover conditions, a construct of Fj a was used in which one of the 
active site disulfide-forming Cys residues was mutated to a Ser (C96S). This variant is 
not active but behaves similarly to the wt a protein in SEC and SAXS. Fj a C96S was 
mixed in a 1:1 ratio with activated Fj b (100 µM of each), 1 mM ATP and 1 mM CDP 
before loading onto a Superdex 200 Increase 10/300 GL column (10 x 300 mm, ~24 mL 
column volume) connected to an ÄKTA Pure FPLC system (GE Healthcare) using a flow 
rate of 0.5 mL min-1. The samples are diluted ~5x on the column. Each frame was 
collected using a 0.5 s exposure, and the protein elution was monitored by UV-vis 
detection at 280 nm.  
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SUPPLEMENTARY FIGURES 
 
Figure S1. Known structures of ring-shaped inhibited forms of class Ia RNRs, all of 
which require a dATP-bound ATP cone (green) on the a protomer. (A) E. coli class Ia 
RNR (PDB ID: 5CNS) sequesters the b2 subunit (blue) to form a4b4 structures. (B) P. 
aeruginosa class Ia RNR (PDB ID: 5IM3) contains two adjacent ATP cones (light/dark 
green). Interactions between the N-terminal cone motifs yield an inhibitory a4 ring. (C) 
Eukaryotic RNR forms similar a6 inhibitory structures with N-terminal ATP-cone 
interfaces (H. sapiens, PDB ID: 6AUI).   
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Figure S2. (A) Fj a crystallizes with two non-crystallographic symmetry-related copies 
of the canonical a2 dimer in the asymmetric unit. Chain D is less complete due to a large 
disordered region (residues 428-487) that could not be modeled. (B) Au a crystallizes 
with a single copy of the a monomer in the asymmetric unit. The canonical a2 dimer 
interface is formed via crystallographic symmetry.  
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Figure S3. The positions of C-terminal tyrosine residues in Fj and Au a are distinct 
from their positions in other structurally characterized class I as.  Zoomed in view of 
the B. subtilis (left, PDB ID: 6CGL), Fj (center) and Au (right) class Id a subunit active 
sites, showing residues contributing to the conserved PCET pathway highlighted in 
boxes. The C-terminal tyrosine residues are unstacked in both Fj and Au class Id a. 
2Fo-Fc electron density map (pink mesh) is shown for the conserved Tyr and Cys 
residues in Au a.  
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Figure S4. Overall secondary structure is conserved between the Fj and Au a crystal 
structures. Top, view of the canonical dimer, and bottom, side view of the monomer.  
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Figure S5. Location of the C-terminal tail in the Au a crystal structure. (A) Canonical 
dimer, (B) zoomed in view, and (C) space-filling model in the Au a crystal structure. (D) 
Zoomed in view of the C-terminal tail (pink) in the Au a monomer (white) and its 
interaction with a crystallographic symmetry mate (gray), at an interface that is distinct 
from the canonical dimer interface. Visible density for residues 549-551 was modeled 
(foreground, black numbering). This region includes one of the two Cys residues 
involved in active site disulfide reduction following turnover. The second Cys side chain 
cannot be definitively modeled due to interaction with an adjacent symmetry mate 
(background, gray numbering). (E) Au a monomer (white) interacting with an adjacent 
symmetry mate (gray) through a crystallographic symmetry interface (dashed line) 
containing C-terminal tail (pink).   
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Figure S6. Schematic diagram illustrating the role of the flexible C-terminal tail in 
disulfide reduction. 1, Prior to reaction with b or the native reducing system, the tail is 
found on the surface of the protein, as seen in the Au structure. 2, After nucleotide 
reduction, the active site disulfide is reduced by two Cys residues found at the C-terminus. 
3, The Cys residues on the tail interact with the native reducing system. 
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Figure S7. (A) Comparison of the E. coli class Ia and F. johnsoniae class Id RNR a 
subunits, illustrating the locations of truncations (blue) and additions (orange) throughout 
the structure. (B) Secondary structure matching superposition of human (Hs) class Ia 
RNR (PDB ID: 3HNF) (multi-color) and Fj class Id RNR (blue) reveals a close match 
throughout most of the core, auxiliary, and connector domains. Exceptions include two 
extended regions in the eukaryotic enzyme that are located in the catalytic domain and at 
the N-terminus (including the ATP-cone).  
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Figure S8. Comparison of the connector domain regions in F. johnsoniae class Id (A), E. 
coli class Ia (PDB ID: 3R1R) (B), B. subtilis class Ib  (PDB ID: 6CGM) (C), T. maritima 
class II (PDB ID: 3O0N) (D), and bacteriophage T4 class III (PDB ID: 1H7A) (E) RNR 
a subunits. Class Id RNRs have a truncated connector domain, similar to class II and 
class III enzymes, and lack the dAMP-binding region in the connector domain found in B. 
subtilis class Ib RNR. 
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Figure S9. Comparison of the auxiliary domain in class Id (A), eukaryotic class Ia (PDB 
ID: 2WGH) (B), and T. maritima class II (PDB ID: 3O0O) (C) RNR a subunits. 
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Figure S10.  A self rotation function analysis, available in the MOLREP program in the 
CCP4 crystallographic suite,2 identifies a six-fold axis of symmetry aligned with the 
longitudinal axis of the helix. The a2 dimer contains a C2 symmetry axis that is 
perpendicular to the 61 axis. The non-crystallographic two-fold axes of symmetry are 
shifted by ~ 10 degrees relative to the cell axes and lower the symmetry of the lattice. 
These observations explain the poor density in chain D of the Fj a structure and are 
consistent with crystallization of a pre-existing fibril form of the protein. 
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Figure S11. Views of a docking model of a class Id a2b2 complex generated via 
secondary-structure matching superposition3 of the Fj a (white/pink space-filling model) 
and b (blue cartoon) subunit structures onto a docking model for E. coli class Ia RNR.  
The predicted b subunit interface on Fj a is highlighted in pink.  In the extended helical 
fibril observed in the x-ray structure of Fj a, we hypothesize that based on the interior 
location of the interface, the extended fibrils would prevent productive b2 complex 
formation due to steric clash with the neighboring monomer. 
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Figure S12. N-terminal interface residues are conserved in the Fj subgroup (top, middle 
panels) but not in the Au subgroup (bottom panel). Surface maps of sequence 
conservation were generated using a MUSCLE alignment of ~100 representative 
sequences from each Id a sub-group, as identified from the SSN and phylogenetic 
analyses shown in Figure 1. 
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Fig S13. SEC-SAXS characterization of Fj a. UV-vis detection at 280 nm (A) and 
integrated scattering intensity (B) of in-line SEC-SAXS experiments of Fj a. The 
molecular weight of both peaks was estimated from the integrated intensity in BioXTAS 
RAW.4 The frames in between the grey dashed lines were chosen for subsequent analysis 
based on their consistent Rg and MW values. The primary peak has an estimated 
molecular weight of 242 kDa and is therefore attributed to the a4 tetramer. The scattering 
curve (C), Kratky plot (D), and P(r) plot (E) all indicate that of Fj a is forming an 
oligomer with two distinct length scales.     
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Figure S14. Characterization of a4 tetramer models. generated using interactions with 
symmetry mates in the crystal structure of Fj a (A, B) and by rigid-body docking of two 
crystallographic dimers using FoxsDock5, 6 (C). Comparisons of theoretical scattering of 
each tetramer (red) with experimental scattering data (black) were calculated using the 
FoXS server.5, 7 Superpositions of each tetramer model with the best ab initio model of 
the molecular envelope of the a4 tetramer are shown. The envelopes were constructed 
using DAMMIF8 and DAMAVER/DAMFILT,9 and overlaid with the crystal structure 
using SUPCOMB.10 The c2 and residual values for the fits suggest that the best model is 
an asymmetric tetramer composed of two canonical dimers.  
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Figure S15. Schematic diagram of quaternary forms of class Id RNR detected in this 
study. Although conditions may exist in which Au RNR a can form fibrils, in this study 
Au a is only observed as a monomer or dimer in solution. The a2 dimer is present in X-
ray structures and would be the precursor to a prototypical a2b2 active enzyme complex.  
Fj RNR a exists in two additional quaternary forms – an a4 tetramer of unknown 
structure and an extended fibril linked by the canonical a2 dimer interface and 
connector/auxiliary domain interfaces. Both the a2 dimer and a4 tetramer may form 
productive complexes with b2 in the active Fj enzyme. 
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Figure S16. SAXS characterization of Fj β. (A) Kratky plot indicating that Fj β has a 
globular shape. (B) Guinier fit indicates that there is no aggregation. (C) Calculated 
molecular envelope superimposed with the crystal structure of Fj b (PDB ID: 6CWP) 
using SUPCOMB.10 (D) Comparison of the experimental scattering data (black) with the 
theoretical scattering curve calculated from the crystal structure (red) using the FoXS 
server.5, 7    
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Fig S17. SEC-SAXS analysis of the Fj a/b complex. (A) UV-vis detection at 280 nm and 
(B) integrated scattering intensity from in-line SEC-SAXS experiments of a 1:1 mixture 
of C96S Fj a and MnIIIMnIV-b, in the presence of 2 mM ATP and 2 mM CDP (to 
simulate turnover conditions), run in buffer containing 50 mM HEPES pH 7.6, 150 mM 
NaCl, 5% (w/v) glycerol, 5 mM DTT, and 12.5 mM MgSO4. The peaks were assigned 
based on Rg values (C) and molecular weight estimates (D) calculated from the integrated 
scattering intensity in BioXTAS RAW.4 
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Figure S18. Allosteric regulation of Fj RNR substrate specificity using MnIII/IV2- b. 
Activities are shown as a percentage relative to the maximum activity for each substrate. 
Maximum activities (in s-1/b) are CDP (ATP) = 1.49 s-1, UDP (ATP) = 0.78 s-1, ADP 
(dGTP) = 0.83 s-1, GDP (dTTP/TTP) = 1.49 s-1. Assays were conducted at 21 ± 2 °C 
using 5 µM b, 25/50 µM a, and DTT as the reductant. 
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Figure S19. Au RNR activity is not inhibited by dATP. 5 µM Au a was assayed in the 
presence of 25 µM Au b, 40 µM Fj Trx, 4 µM Fj TRR, 1 mM NADPH, 12.6 mM MgSO4, 
2 mM CDP, and variable amounts of ATP/dATP. The lower rate relative to Fj RNR may 
be due to use of the Fj reducing system for the Au RNR.  
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Figure S20. Addition of nucleotides does not have a significant effect on the overall 
shape and oligomeric structure of Fj a. (A) Kratky representations of the scattering 
curves (Iq2 vs q) of 20 µM Fj a (in the presence of 2 mM CDP) with 0 µM (blue) and 20 
µM dATP (red). (B) Kratky representations of 20 µM Fj a in the presence of 0 mM ATP 
(blue), 0.1 mM ATP (green), 0.6 mM ATP (orange), and 2 mM (brown) ATP shows very 
little change, indicating that ATP binding does not have a significant effect on the overall 
structure. All samples were in buffer D with 2 mM CDP. 
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Table S1.  Data collection and refinement statistics for x-ray structures of RNR α 
subunits. 
 
 Fj α Au α  
Data collection    
Space group 
Wavelength (Å) 
P61 
0.97872 
P42212 
1.0332 
 
Cell dimensions      
    a, b, c (Å) 161.0, 161.0, 187.7 97.98, 97.98,132.01  
    a, b, g  (°)  90.0, 90.0, 120.0 90.0, 90.0, 90.0  
Resolution (Å) 50.0-2.60 (2.64-2.60)* 50.0-1.76 (1.79-1.76)  
Rmerge 0.104 (0.946) 0.059 (0.605)  
Rpim 0.031 (0.276) 0.023 (0.267)  
I / sI 26.8 (3.0) 33.0 (2.9)  
CC1/2 0.673 (0.891)  
Completeness (%) 99.8 (99.2) 97.8 (86.0)  
Redundancy 11.6 (11.6) 7.2 (4.8)  
    
Refinement    
Resolution (Å) 50.0-2.60 50.0-1.76  
No. reflections 80627 63821  
Rwork / Rfree 0.206/0.251 0.192/0.224  
No. atoms    
    Protein 15184 4177  
    Ligand/ion 0 26  
    Water 134 259  
B-factors    
    Protein 47.3 23.5  
    Ligand/ion - 40.8  
    Water 30.4 26.5  
R.m.s. deviations    
    Bond lengths (Å) 0.006 0.0103  
    Bond angles (°) 1.037 1.377  
Molprobity clashscore 3.01 (100th percentile) 1.81 (100th percentile)  
Rotamer outliers (%) 2 0  
Ramachandran favored (%) 97 97  
*Values in parentheses are for highest-resolution shell. 
 
 	
Table S2. SAXS parameters for Fj a over a series of protein concentrations  
Sample conc. 
(µM) 
Rg (Guinier) Dmax (Å) MW, kDa 
(Vp)11 
MW, kDa 
(Vc)12 
Porod Volume 
(nm3) 
10 47.8 166 234.1 197.5 316 
20 47.3 157 237.1 206.3 330 
35 48.6 159 224.3 200.0 320 
50 48.8 165 235.8 205.6 328 
avg 48.13 ± 0.61 161.8 ± 3.8 232.8 ± 5.0 202.4 ± 3.7 323.5 ± 5.7 
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Table S3. SAXS parameters from flow-cell and SEC-SAXS measurements of Fj a and 
b 
Sample Rg 
(Guinier) 
Dmax (Å) MW, kDa 
(Vp)11 
MW, kDa 
(Vc)12 
Porod Volume 
(nm3) 
Flow Cell a 49.35 ± 0.68 166.8 ± 9.1 211.3 ± 8 211± 11 310.1 ± 6.8 
SEC-SAXS a 48.40 160.15 242 271 337 
a + 20 µM dATP 48.84 166.6 227.4 246.8 326 
a + 0.1 mM ATP 49.32 181.5 225.8 221.5 333 
a + 0.6 mM ATP 49.13 161.0 246.3 232.4 332 
a + 2 mM ATP 48.96 173.9 242.9 230.2 333 
b 29.65 98.74 86 76.1 111 
 
Table S4. Parameters for ab initio shape reconstructions of Fj a and b 
Sample a b 
Data used SEC-SAXS SEC-SAXS 
Q range 0.0-0.1653 0.0-0.176 
Shape reconstruction DAMMIF/slow DAMMIF/fast 
Symmetry P2 (oblate) P1 
c2 1.046 0.063 
DAMMIF search space default default 
# Models averaged/total 10/10 10/10 
DAMAVER NSD (var) 1.286 (0.180) 0.507 (0.016) 
DAMAVER excluded volume 440900.000 150100.000 
Filtered volume (from DAMFILT) 441022.296  
 
Table S5. Comparison of fit parameters for the possible tetramers with the ab initio 
model. The excluded volume and NSD values were found using the alignment program 
SUPCOMB when the DAMFILT model was aligned to the tetramer models.  
Tetramer Model Excluded Volume NSD 
1 123661 2.89 
2 123661 2.44 
3 123661   2.11 
 
Table S6. Volume fractions of components from hypothetical model combinations using 
OLIGOMER.13 
Sample Tetramer 1 
+ dimer 
Tetramer 2 
+ dimer 
Tetramer 3 
+ dimer 
Tetramer 1 + 2 + 3 + dimer 
Vol. fraction tetramer 100 % 100 % 96.7 % 0 % 1 0 % 2 96.7 % 3 
Vol. fraction dimer 0 % 0 % 3.3 %    3.3 %  
c2	 12.47 19.26 3.74       3.95  
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